NCT04231279View on ClinicalTrials.gov

Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency

PHASE3TerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 28, 2022

Primary Completion Date

June 15, 2023

Study Completion Date

June 15, 2023

Conditions
Abdominal PainIrritable Bowel Syndrome
Interventions
DRUG

synthetic human secretin

Secretin is a gastrointestinal peptide hormone, indicated for the stimulation of: pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction.

Trial Locations (1)

32806

Orlando Health - Arnold Palmer Children's Hospital, Orlando

Sponsors

Collaborators (1)

ChiRhoClin, Inc.
All Listed Sponsors
collaborator

ChiRhoClin, Inc.

INDUSTRY

lead

Orlando Health, Inc.

OTHER